NDI-034858 free base · Synonyms: Zasocitinib | TAK-279
NDI-034858 is a TYK2 inhibitor.
For research use only. Not for human or veterinary use.
Target
JAK
Research area
Inflammation/Immunology
Purity >99.5% SFC
Stock Inquire
NDI-034858 structure
CAS No.: 2272904-53-5
Pack sizes & pricing
Description
NDI-034858 is a TYK2 inhibitor, target TYK2 JH2 domain with binding constant Kd of <200 pM.
Biological activity
Zasocitinib (10 μM) exhibits inhibitory effect on Tyk2 and JAK by targeting Tyk2 JH1 and JAK JH1 domain with inhibition rates <50%, respectively Zasocitinib inhibits phosphorylation induction of heterodimer complex Tyk2 /JAK2-mediated IL-12 (1.7 ng/mL) effect, with IC50 value of <0.1 μM in human peripheral blood mononuclear cell
Identifiers
- SMILES
-
CO[C@H](CC1)[C@@H]1NC(C2=C3N(N=C2)C(NC)=CC(NC4=CC=CN(C5=CC=CC=N5)C4=O)=N3)=O - InChIKey
-
BWINBHTTZLVXGT-NVXWUHKLSA-N
Specifications
- MW (average)
- 460.4885
- Formula
- C23H24N8O3
- CAS No.
- 2272904-53-5
- Physical state
- Solid
- Color
- Off-white to light yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 1 month
Solubility
Soluble in DMSO : 50 mg/mL
Documents
References
[1]. Leit, Silvana et al. “Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279.” Journal of medicinal chemistry vol. 66,15 (2023): 10473-10496.
[2]. Masse, Craig E, et al. Pyrazolopyrimidines as TYK2 inhibitors and their preparation: World Intellectual Property Organization, WO2019023468. 2019-01-31.
Same target
Search JAK- BP-01476 ZM 449829 free base · >98%
- BP-01841 CYT-387 free base · >98%
- BP-01903 Deucravacitinib free base · >99%
- BP-01938 Clifutinib free base · >98%
- BP-01993 AZD4604 free base · >98%
- BP-02218 AZD1480 free base · >98%
- BP-02300 NVP-BSK 805 free base · >98%
- BP-02300A NVP-BSK805 dihydrochloride salt · >98%